Academic publishing in Europe and N. America

Archive Publication ethics Submission Payment Contacts
In the original languageTranslation into English

Impact of CD4+ Lymphocyte Distribution on the Immune Microenvironment, Morphological Changes, and Therapeutic Outcomes in Soft Tissue Sarcomas

Authors

Polatova Jamila Shagayratovna, Karimova Nargiza Mansurovna, Kahharov Alisher Jamoliddinovich

Rubric:Medical science
1145
0
Download articleQuote
1145
0

Annotation

This study examines the significance of CD4 lymphocyte localization in the tumor microenvironment of soft tissue sarcomas and their impact on the efficacy of therapy. The analysis showed that intratumoral (intra-umoral) infiltration of these cells is significantly associated with pronounced morphological regression and a high level of therapeutic pathomorphosis, indicating the important role of immune mechanisms in the formation of an antitumor response. Localization of CD4+ T lymphocytes inside the tumor enhances the immune response, stimulates cytotoxic cells and helps to reduce tumor volume, which confirms the theoretical concept of strengthening local immune activation to improve treatment efficacy. At the same time, the effect of CD4 lymphocyte localization on short-term clinical indicators of responses to therapy (complete, partial, stabilization, progression) was statistically insignificant, which indicates the need for further research for a deeper understanding of the mechanisms of interaction between immune cells and the therapeutic effect. The data obtained emphasize the prospects of using CD4 lymphocyte localization as a prognostic marker for assessing the morphological and long-term response, as well as for the development of new methods for optimizing immunotherapy for soft tissue sarcomas.

Keywords

soft tissue sarcoma
chemotherapy
radiation therapy
tumor microenvironment

Authors

Polatova Jamila Shagayratovna, Karimova Nargiza Mansurovna, Kahharov Alisher Jamoliddinovich

References:

1.       Huang H, Fan Y, Zhang S, Bai X, Wang X, Shan F. Emerging immunotherapy and tumor microenvironment for advanced sarcoma: a comprehensive review. Front Immunol. 2025 May 21;16:1507870. doi: 10.3389/fimmu.2025.1507870. PMID: 40469285; PMCID: PMC12133756

2.       van der Graaf WTA, Orbach D, Judson IR, Ferrari A. Soft tissue sarcomas in adolescents and young adults: A comparison with their paediatric and adult counterparts. Lancet Oncol. (2017) 18:e166–e75. doi:  10.1016/s1470-2045(17)30099-2

3.       Lee AQ, Hao C, Pan M, Ganjoo KN, Bui N. Use of histologic and immunologic factors in sarcoma to predict response rates to immunotherapy. J Clin Oncol. (2024) 42:11569. doi:  10.1200/JCO.2024.42.16_suppl.11569

4.       Wood GE, Meyer C, Petitprez F, D’Angelo SP. Immunotherapy in sarcoma: current data and promising strategies. Am Soc Clin Oncol Educ Book. (2024) 44:e432234. doi:  10.1200/edbk_432234

5.       Recine F, Vanni S, Bongiovanni A, Fausti V, Mercatali L, Miserocchi G, et al. Clinical and translational implications of immunotherapy in sarcomas. Front Immunol. (2024) 15:1378398. doi:  10.3389/fimmu.2024.1378398

Other articles of the issue

Otenova Farida Tolegenovna, Abilova Aizada Azamatovna, Baltabaev Muratbay Toremuratovich BOTANICAL AND MORPHOLOGICAL CHARACTERISTICS OF POPULUS PRUINOSA
Download article in PDF1295 views
cc-license
About us Journals Books
Publication ethics Terms of use of services Privacy policy
Copyright 2013-2025 Premier Publishing s.r.o.
Praha 8 - Karlín, Lyčkovo nám. 508/7, PSČ 18600, Czech Republic pub@ppublishing.org